Loss of P16 Protein Expression and Its Association with Epstein‐Barr Virus LMP‐1 Expression in Hodgkin's Lymphoma


avatar Fawzi Irshaid 1 , * , avatar Khaled Tarawneh 2 , avatar Aisha Alshdefat 3 , avatar Fatiha Dilmi 1 , avatar Adnan Jaran 1 , avatar Raji Al‐Hadithi 4 , avatar Ahad Al‐Khatib 4

Dept. of Biological Sciences, Faculty of Science, Al al-Bayt University, Al-Mafraq, Jordan
Dept. of Biological Sciences, Faculty of Science, Mutah University, Mutah, Jordan
Mafraq Hospital of Children and Maternity, Al-Mafraq, Jordan
Dept. of Pathology, Faculty of Medicine, Jordan University of Sciences and Technology, Irbid, Jordan

how to cite: Irshaid F , Tarawneh K, Alshdefat A, Dilmi F, Jaran A, et al. Loss of P16 Protein Expression and Its Association with Epstein‐Barr Virus LMP‐1 Expression in Hodgkin's Lymphoma. Int J Cancer Manag. 2013;6(2):e80404.


Background: Expression of Epstein-Barr virus Latent Member Protein-1 (EBV LMP1) and loss of P16 protein expression are documented in lymphoma, indicating a relationship between them, but this relationship is not clear and sometimes contradictory. Thus, this study was conducted to examine the relationship between the loss of P16 and EBV LMP-1 expression in Jordanian patients diagnosed with lymphoma.
Methods: Sections were made from archival formalin-fixed and paraffinembedded blocks from 55 patients diagnosed with lymphoma. P16 expression and LMP-1 expression were detected by immunohistochemistry using monoclonal antibodies.
Results: In Hodgkin's Lymphoma (HL), the loss of P16 was higher in LMP-1 positive cases (61%) than LMP-1 negative cases (25%; P = 0.072). Conversely, in NonHodgkin's Lymphoma (NHL), none of LMP-1 positive samples showed loss of P16. Furthermore, among LMP-1 HL positive cases, the loss of P16 was more frequent in male (75%) than female (33%). Also, there was a significantly higher proportion of LMP-1 positive cases showing loss of P16 in HL (11:18), compared to those in NHL (0:8, P < 0.001), confirming a difference between HL and NHL, concerning the LMP-1/P16 relationship.
Conclusion: A trend for an association between loss of P16 and LMP-1 expression was observed in HL but not NHL patients. These findings suggest that there are molecular and clinical differences in the pathogenesis and development of different subtypes of lymphoma.


The Full text is available in PDF.

© 2013, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.